Skip to main content
Feedback to SSRN
Feedback
(required)
Email
(required)
Submit
Alexandre Lolivier
Gustave Roussy
Villejuif
France
Contact
Gustave Roussy
Email
Learn more about SSRN Profiles
SCHOLARLY PAPERS
1
DOWNLOADS
93
TOTAL CITATIONS
0
Feedback
Scholarly Papers (1)
Sort by:
Paper Title, A-Z
Paper Title, Z-A
Author Name, A-Z
Author Name, Z-A
Date Posted, Ascending
Date Posted, Descending
Downloads, Ascending
Downloads, Descending
Citations, Ascending
Citations, Descending
Actions:
Email selected abstracts
View:
Selected
Original List
All Versions
Hide All Versions
All Abstracts
Hide All Abstracts
(Rank)
1.
Overall Survival Impact of Pembrolizumab Duration and Comorbidities on Advanced NSCLC: A Nationwide Cohort Study
Number of pages: 37
Posted: 05 Mar 2024
Adrien Rousseau
,
Stefan Michiels
,
Julian Bonastre
, Alexandre Lolivier,
David Planchard
,
Fabrice Barlesi
,
Jordi Remon
,
Pernelle Lavaud
,
Mihaela Aldea
,
Maxime Frelaut
,
Cecile Le Pechoux
,
Angela Botticella
,
Antonin Levy
,
Anas Gazzah
,
Stéphanie Foulon
and
Benjamin Besse
Gustave Roussy, University of Paris-Saclay, Gustave Roussy, Gustave Roussy, Gustave Roussy, Gustave Roussy, Gustave Roussy, Gustave Roussy, Gustave Roussy, Gustave Roussy, Université Paris XI Sud - Institut Gustave Roussy/Gustave Roussy Villejuif, Gustave Roussy, Gustave Roussy, Gustave Roussy - Drug Development Department (DITEP), Gustave Roussy and Comité de Pathologies Thoraciques
Downloads
93
(725,554)
View PDF
Download
Abstract:
Pembrolizumab, NSCLC, Cohort, Real-life data, IPTW
Feedback
